DOI QR코드

DOI QR Code

The use of animal models in rheumatoid arthritis research

  • Jin-Sun Kong (Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea) ;
  • Gi Heon Jeong (Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea) ;
  • Seung-Ah Yoo (Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea)
  • 투고 : 2022.10.18
  • 심사 : 2022.11.04
  • 발행 : 2023.01.31

초록

The pathological hallmark of rheumatoid arthritis (RA) is a synovial pannus that comprises proliferating and invasive fibroblast-like synoviocytes, infiltrating inflammatory cells, and an associated neoangiogenic response. Animal models have been established to study these pathological features of human RA. Spontaneous and induced animal models of RA primarily reflect inflammatory aspects of the disease. Among various induced animal models, collagen-induced arthritis (CIA) and collagen antibody-induced arthritis (CAIA) models are widely used to study the pathogenesis of RA. Improved transplantation techniques for severe combined immunodeficiency (SCID) mouse models of RA can be used to evaluate the effectiveness of potential therapeutics in human tissues and cells. This review provides basic information on various animal models of RA, including CIA and CAIA. In addition, we describe a SCID mouse coimplantation model that can measure the long-distance migration of human RA synoviocytes and cartilage destruction induced by these cells.

키워드

과제정보

This work was supported by grants from the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2019R1A2C2010897).

참고문헌

  1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19. https://doi.org/10.1056/NEJMra1004965
  2. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010;233:233-55. https://doi.org/10.1111/j.0105-2896.2009.00859.x
  3. Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki M, Nishioka K, et al. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera. J Rheumatol 2002;29:1609-14.
  4. Yoo SA, Park JH, Hwang SH, Oh SM, Lee S, Cicatiello V, et al. Placental growth factor-1 and -2 induce hyperplasia and invasiveness of primary rheumatoid synoviocytes. J Immunol 2015;194:2513-21. https://doi.org/10.4049/jimmunol.1402900
  5. Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-20. https://doi.org/10.1038/nm.2050
  6. Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum 2007;56:4015-23. https://doi.org/10.1002/art.23063
  7. Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, et al. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 2002;168:5867-75. https://doi.org/10.4049/jimmunol.168.11.5867
  8. Marinova-Mutafchieva L, Gabay C, Funa K, Williams RO. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint. Clin Exp Immunol 2006;146:287-93. https://doi.org/10.1111/j.1365-2249.2006.03204.x
  9. Lee KM, Zhang Z, Achuthan A, Fleetwood AJ, Smith JE, Hamilton JA, et al. IL-23 in arthritic and inflammatory pain development in mice. Arthritis Res Ther 2020;22:123.
  10. Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005;12:167-81. https://doi.org/10.1016/j.pathophys.2005.07.011
  11. Chu CQ, Song Z, Mayton L, Wu B, Wooley PH. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis 2003;62:983-90. https://doi.org/10.1136/ard.62.10.983
  12. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198:1951-7. https://doi.org/10.1084/jem.20030896
  13. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004;50:650-9. https://doi.org/10.1002/art.20001
  14. Brackertz D, Mitchell GF, Mackay IR. Antigen-induced arthritis in mice: I. Induction of arthritis in various strains of mice. Arthritis Rheum 1977;20:841-50. https://doi.org/10.1002/art.1780200314
  15. Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 2001;1:377-85.
  16. Razawy W, Asmawidjaja PS, Mus AM, Salioska N, Davelaar N, Kops N, et al. CD4+ CCR6+ T cells, but not γδ T cells, are important for the IL-23R-dependent progression of antigen-induced inflammatory arthritis in mice. Eur J Immunol 2020;50:245-55. https://doi.org/10.1002/eji.201948112
  17. Cornelissen F, Mus AM, Asmawidjaja PS, van Hamburg JP, Tocker J, Lubberts E. Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells. Arthritis Res Ther 2009;11:R194.
  18. Glant TT, Mikecz K, Bartlett RR, Deak F, Thonar EJ, Williams JM, et al. Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomide. Immunopharmacology 1992;23:105-16. https://doi.org/10.1016/0162-3109(92)90034-A
  19. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987;30:306-18. https://doi.org/10.1002/art.1780300310
  20. Kaplan C, Valdez JC, Chandrasekaran R, Eibel H, Mikecz K, Glant TT, et al. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res 2002;4:54-8. https://doi.org/10.1186/ar383
  21. Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, et al. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J Immunol 2010;184:1552-9. https://doi.org/10.4049/jimmunol.0902907
  22. Nandakumar KS, Holmdahl R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods 2005;304:126-36.
  23. Nandakumar KS, Backlund J, Vestberg M, Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004;6:R544-50. https://doi.org/10.1186/ar1217
  24. Moore AR, Allden S, Bourne T, Denis MC, Kranidioti K, Okoye R, et al. Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritis. J Transl Med 2014;12:285.
  25. Zhao T, Xie Z, Xi Y, Liu L, Li Z, Qin D. How to model rheumatoid arthritis in animals: from rodents to non-human primates. Front Immunol 2022;13:887460.
  26. Wang C, Wang W, Jin X, Shen J, Hu W, Jiang T. Puerarin attenuates inflammation and oxidation in mice with collagen antibody-induced arthritis via TLR4/NF-κB signaling. Mol Med Rep 2016;14:1365-70. https://doi.org/10.3390/molecules21101365
  27. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31. https://doi.org/10.1002/j.1460-2075.1991.tb04978.x
  28. Williams RO, Feldmann M, Maini RN. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha. Ann Rheum Dis 2000;59(Suppl I):i75-80. https://doi.org/10.1136/ard.59.suppl_1.i75
  29. Joe B, Griffiths MM, Remmers EF, Wilder RL. Animal models of rheumatoid arthritis and related inflammation. Curr Rheumatol Rep 1999;1:139-48. https://doi.org/10.1007/s11926-999-0011-7
  30. Kinne RW, Stuhlmuller B, Burmester GR. Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther 2007;9:224.
  31. Horai R, Nakajima A, Habiro K, Kotani M, Nakae S, Matsuki T, et al. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J Clin Invest 2004;114:1603-11. https://doi.org/10.1172/JCI20742
  32. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20. https://doi.org/10.1084/jem.191.2.313
  33. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003;100:5986-90. https://doi.org/10.1073/pnas.1035999100
  34. Duchosal MA. SCID mice in the study of human autoimmune diseases. Springer Semin Immunopathol 1992;14:159-77. https://doi.org/10.1007/BF00195292
  35. Elkon KB, Ashany D. The SCID mouse as a vehicle to study autoimmunity. Br J Rheumatol 1993;32:4-12. https://doi.org/10.1093/rheumatology/32.1.4
  36. Schinnerling K, Rosas C, Soto L, Thomas R, Aguillon JC. Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies. Front Immunol 2019;10:203.
  37. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
  38. You S, Yoo SA, Choi S, Kim JY, Park SJ, Ji JD, et al. Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Natl Acad Sci U S A 2014;111:550-5. https://doi.org/10.1073/pnas.1311239111
  39. Dang J, Zhu S, Wang J. A protocol for humanized synovitis mice model. Am J Clin Exp Immunol 2019;8:47-52.